RPID

$0.69-0.12%visit website

RAPID MICRO BIOSYSTEMS, INC.

Market Cap

$35M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

1.54

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

1.0

TTM to Jun 2026 · revenue

P/B

2.0

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	7,838	11,282	8,002	8,054	35,176
Cost of revenue			7,631	6,842
Gross profit			371	1,212
Research & development	3,529	3,220	3,359	3,332	13,440
Total operating expenses			14,223	13,534
Operating income	(11,372)	(12,211)	(13,852)	(12,322)	(49,757)
Interest expense	393	673	639	646	2,351
Income tax	8.0	14.0	8.0	45.0	75.0
Net income	(11,505)	(12,497)	(14,275)	(12,923)	(51,200)
EPS (basic) ($)	(0.26)		(0.31)	(0.27)	(1.11)
EPS (diluted) ($)	(0.26)		(0.31)	(0.27)	(1.11)
Weighted avg. shares (basic)	44,956		45,434	48,347
Weighted avg. shares (diluted)	44,956		45,434	48,347

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 7, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 21 more quarters, back to Jun 2020, with Tormere Pro.

Corporate Events (8-K)

8 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 7, 2026 accepted 7:02 AM ET	2.02Earnings release	Document SEC ↗
May 28, 2026 accepted 4:14 PM ET	5.07Shareholder vote	Document SEC ↗
May 19, 2026 accepted 5:13 PM ET	1.01Material agreement	Document SEC ↗
May 13, 2026 accepted 4:33 PM ET	2.02Earnings release	Document SEC ↗
Mar 27, 2026 accepted 4:34 PM ET	5.02Officer / director change	Document SEC ↗
Mar 12, 2026 accepted 7:02 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jan 13, 2026 accepted 4:16 PM ET	2.02Earnings release	Document SEC ↗
Nov 7, 2025 accepted 6:03 AM ET	2.02Earnings release	Document SEC ↗
Aug 12, 2025 accepted 6:33 AM ET	1.01Material agreement2.02Earnings release2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
Jun 17, 2025 accepted 5:30 PM ET	8.01Other events	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

48%

W/W +19.8pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-03-11	2026-03-12	Wilson John J. Addington	CHIEF OPERATING OFFICER	Sale	9,603	$4.32	$41K	316.8K	View
2026-03-11	2026-03-12	WIRTJES SEAN M	CHIEF FINANCIAL OFFICER	Sale	7,480	$4.32	$32K	556.2K	View
2026-03-10	2026-03-12	Spignesi Robert G. Jr.	Director & PRESIDENT AND CEO	Sale	17.9K	$4.11	$74K	1.17M	View
2026-02-20	2026-02-20	Wilson John J. Addington	CHIEF OPERATING OFFICER	Sale	5,403	$3.92	$21K	326.4K	View
2026-02-20	2026-02-20	WIRTJES SEAN M	CHIEF FINANCIAL OFFICER	Sale	17.3K	$3.92	$68K	563.7K	View